PRRT2 and Alzheimer disease: PKC–Ras signaling can be upregulated to compensate for loss of M1 muscarinic acetylcholine receptor activity and thereby mitigate dementia symptoms in elderly (Chen et al., 2020), and our results imply that the same may be true for AD.